Activity Overview
This educational activity is an archive of the live presentation held on April 11, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists, surgical oncologists, radiation oncologists, gastroenterologists, and hepatologists who are interested in the treatment of gastrointestinal (GI) cancers. Nurse practitioners, physician assistants, nurses, pathologists, pharmacists, and other health care professionals involved in the treatment and management of patients with GI cancers are invited to attend.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Assess the clinical utility of novel molecular and genomic strategies for personalizing treatment decisions in patients with GI cancers
- Evaluate the clinical impact of recent findings from landmark trials of emerging treatment strategies for the management of GI cancers
- Apply evolving evidence into individualized, multidisciplinary care strategies to improve outcomes for patients with GI cancers
- Implement best practices for preventing, recognizing, and managing TRAEs associated with novel therapies used for the management of GI cancers
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here